CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Jul 15, 2024
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
© 2024 CSRXP- All Rights Reserved
Updates
ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN
Jul 15, 2024
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Jul 11, 2024
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Jul 2, 2024
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”
Jun 26, 2024
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM
Jun 25, 2024
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
SECOND OPINION: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS ARE THE ROOT CAUSE OF HIGH DRUG PRICES
Jun 17, 2024
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
DOSE OF REALITY: FORBES: MAKING IT HARDER TO CHALLENGE BIG PHARMA’S PATENT THICKETS WOULD RAISE DRUG PRICES, UNDERMINE TRUE INNOVATION
Jun 5, 2024
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA STIFLES COMPETITION WITH PRODUCT SHOPPING
May 23, 2024
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More
THEY SAID IT!: LAWMAKERS ROAST BIG PHARMA’S PATENT ABUSE, CALL FOR ACTION ON BIPARTISAN SOLUTIONS TO HOLD THE PHARMACEUTICAL INDUSTRY ACCOUNTABLE
May 22, 2024
Senate Judiciary Committee Puts Spotlight on Big Pharma’s Anti-Competitive… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE BLOCKS COMPETITION IN THE PRESCRIPTION DRUG MARKET, KEEPS DRUG PRICES HIGH
May 21, 2024
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
DOSE OF REALITY: STUDY FINDS NEARLY THREE-QUARTERS OF BIG PHARMA’S PATENTS ON TOP-SELLING DRUGS FILED AFTER FDA APPROVAL
May 16, 2024
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on… Read More